Literature DB >> 31943295

Novel 3-aryl-5-substituted-coumarin analogues: Synthesis and bioactivity profile.

Eleni Kavetsou1, Annita Katopodi1,2, Letta Argyri2, Eirini Chainoglou3, Eleni Pontiki3, Dimitra Hadjipavlou-Litina3, Angeliki Chroni2, Anastasia Detsi1.   

Abstract

Eighteen 3-aryl-5-substituted-coumarins-six 5-acetyloxy-derivatives, six 5-hydroxy-derivatives, and six 5-geranyloxy-derivatives-were synthesized, structurally characterized and their antioxidant activity, lipoxygenase inhibitory ability, as well as their cytotoxic activity against human neuroblastoma SK-N-SH and HeLa adenocarcinoma cell lines were evaluated. The 5-acetyloxy-compounds 3a-3f were found to be the best cytotoxic agents among all the compounds studied. The bromo-substituted coumarins 3a and 3b were remarkably active against HeLa cell line showing IC50 1.8 and 6.1 μM, respectively. Coumarin 5e possessing a geranyloxy-chain on position 5 of the coumarin scaffold presented dual bioactivity, while 5-geranyloxy-coumarin 5f was the most competent soybean lipoxygenase inhibitor of this series (IC50 10 μM). As shown by in silico docking studies, the studied molecules present allosteric interactions with soybean lipoxygenases.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  acetyloxy-moiety; coumarins; cytotoxicity; lipoxygenase; molecular modeling; oxyprenylated analogues

Mesh:

Substances:

Year:  2020        PMID: 31943295     DOI: 10.1002/ddr.21639

Source DB:  PubMed          Journal:  Drug Dev Res        ISSN: 0272-4391            Impact factor:   4.360


  2 in total

Review 1.  3-Phenylcoumarins as a Privileged Scaffold in Medicinal Chemistry: The Landmarks of the Past Decade.

Authors:  Maria J Matos; Eugenio Uriarte; Lourdes Santana
Journal:  Molecules       Date:  2021-11-08       Impact factor: 4.411

2.  Semisynthesis of Selenoauraptene.

Authors:  Serena Fiorito; Francesco Epifano; Lorenzo Marchetti; Salvatore Genovese
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.